Cases & Deals

STERIS signs $2.55 billion financing package in connection with acquisition of Cantel Medical

Clients STERIS plc

Jones Day represented STERIS plc, a leading provider of infection prevention and other procedural products and services, in connection with a new (i) $1.25 billion revolving credit facility, (ii) $550 million term loan facility, and (iii) $750 million delayed draw term loan facility with JPMorgan Chase Bank, N.A., as administrative agent, the proceeds of which will be used, in part, to finance the acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.